← Back to Search

Behavioral Intervention

Text Messaging for HIV Prevention

N/A
Recruiting
Led By Michelle Henshaw, DDS, MPH
Research Sponsored by Boston University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
A woman who reports having sex exclusively with women
Self-report of having HIV infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months, 6 months, 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will last for 3 years and aims to determine if text messages can effectively help prevent HIV in dental patients. The study will involve 266 participants from 4 community health centers who will either

Who is the study for?
This trial is for English or Spanish-speaking dental patients at certain health centers who have HIV risk factors like multiple sex partners, but are not HIV-positive. They must be able to give informed consent and commit to the study's duration.
What is being tested?
The study tests a text message program over three years. Participants will receive texts about either HIV prevention or general wellness. The goal is to see if these messages can help reduce the risk of getting HIV.
What are the potential side effects?
Since this trial involves receiving and responding to text messages, there are no direct medical side effects associated with traditional interventions such as medications or procedures.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am a woman who has sex exclusively with women.
Select...
I have HIV.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants that obtain HIV testing
Secondary study objectives
Adherence to pre-exposure prophylaxis (PrEP)
Condom use
Intravenous Drug Use (IDU)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HIV text messages (TM HIV)Experimental Treatment1 Intervention
Eligible participants randomized into this arm will receive text messages to reduce the risk for HIV and promote HIV testing.
Group II: TM HLActive Control1 Intervention
Eligible participants randomized into this arm will receive text messages to promote healthy living, but not specific to HIV risk or testing..

Find a Location

Who is running the clinical trial?

National Institute of Dental and Craniofacial Research (NIDCR)NIH
306 Previous Clinical Trials
849,804 Total Patients Enrolled
Boston UniversityLead Sponsor
472 Previous Clinical Trials
9,987,567 Total Patients Enrolled
Michelle Henshaw, DDS, MPHPrincipal InvestigatorBoston University Goldman School of Dental Medicine
~177 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top